Clinical Trials on HIV-1 in Switzerland

Total 282 results

University of Zurich

Active, not recruiting

BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection: (BELIEVE)

HIV-1-infection

Switzerland
ANRS, Emerging Infectious Diseases
Imperial College London; University College, London; Fred Hutchinson Cancer Center and other collaborators

Terminated

An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection (EHVAT01)

HIV-1-infection

Switzerland, United Kingdom
Pfizer

Completed

A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1

HIV-1

United Kingdom, South Africa, Australia, Canada, Italy, Poland, Switzerland, Argentina, Mexico
Pfizer
ViiV Healthcare

Terminated

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

HIV-1

South Africa, Australia, United Kingdom, Canada, Italy, Poland, Switzerland, Mexico, Brazil
Pfizer
ViiV Healthcare

Terminated

A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1

HIV-1

United States, United Kingdom, Portugal, Ukraine, Italy, Poland, Switzerland, Argentina, South Africa, Puerto Rico, Brazil, Malaysia
ViiV Healthcare
Pfizer

Completed

Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine (MERIT)

HIV-1

United States, Canada, United Kingdom, Netherlands, Argentina, Australia, Belgium, South Africa, Switzerland, Italy, Puerto Rico, Brazil, Mexico, Poland
University Hospital, Basel, Switzerland
ITI International Team for Implantology, Switzerland

Recruiting

Supplementary Implants Supporting Conventional Removable Dental Prosthesis (RDPs) in Kennedy Class I

Partial Edentulism Kennedy Class 1

Switzerland
Spiden AG
DCB Research AG

Recruiting

A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults With Type-1 Diabetes Mellitus

Type 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With Hyperglycemia

Switzerland
ANRS, Emerging Infectious Diseases
University College London Hospitals; Hospital Clinic of Barcelona; Imperial College... and other collaborators

Completed

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

HIV-1-infection

France, United Kingdom, Switzerland
ViiV Healthcare
Pfizer

Terminated

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 (MODERN)

HIV-1

United States, Netherlands, Spain, Puerto Rico, Canada, Australia, Germany, Sweden, Poland, Portugal, Switzerland, France, Denmark, Italy, Belgium, United Kingdom, Hungary, Austria, Finland
University Hospital, Geneva
Swiss National Science Foundation

Completed

Exercise Training Intervention in Children With Type 1 Diabetes (Diabex)

Type 1 Diabetes Mellitus

Switzerland
University Hospital Inselspital, Berne
University of Lausanne; University of Bern

Completed

Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes (CARBEX1)

Hypoglycemia | Exercise | Type 1 Diabetes Mellitus | Carbohydrate Metabolism

Switzerland
University Hospital Inselspital, Berne

Completed

Fructose in Exercising Individuals With Type 1 Diabetes Using Insulin Degludec (FruDeg)

Diabetes Complications | Type 1 Diabetes Mellitus

Switzerland
Psychiatric University Hospital, Zurich
University of Basel

Completed

Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects

Emotions | Mood | Cognitive Function 1, Social | Empathy

Switzerland
Calmy Alexandra

Completed

Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV) (Simpl'HIV)

Antiretroviral Therapy | HIV-1-infection | Maintenance Therapy

Switzerland
University Hospital, Geneva
Merck Sharp & Dohme LLC; Center for Primary Care and Public Health (Unisante)...

Completed

Understanding Barriers and Facilitators to the Participation of Women Living With HIV in Clinical Trials : a Mixed-method Study (EVA) (EVA)

HIV

Switzerland
Pediatric Clinical Research Platform
University Hospital, Geneva; University of Geneva, Switzerland

Recruiting

Mechanisms of Type 1 Diabetes Endophenotypes (METYDIA)

Genetic Predisposition to Disease | Type 1 Diabetes Mellitus

Switzerland
Christian Meier
University Hospital Inselspital, Berne; University Hospital, Basel, Switzerland and other collaborators

Completed

Microarchitecture, Bone Strength and Fracture Risk in Long-term Type 1 Diabetes (BOLD-1)

Type 1 Diabetes Mellitus

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Pancreatic Islet Transplantation in the Anterior Chamber of the Human Eye - a Pilot Study

Type 1 Diabetes Mellitus

Switzerland
University Children's Hospital, Zurich

Completed

Risk Factors of Metabolic Control in Children and Adolescents With Type 1 Diabetes

Type 1 Diabetes

Switzerland
University Hospital, Geneva

Terminated

Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging

Type 1 Diabetes Mellitus

Switzerland
Jules Desmeules

Terminated

Impact of Antiretroviral Treatment on Pharmacokinetics and Pharmacodynamics of Thienopyridines in Healthy Volunteers and HIV Patients (IMPACT/R)

Hiv

Switzerland
Alain Nordmann

Terminated

Smartphone App and CO Self-monitoring for Smoking Cessation (SMART-CO)

Smoking | HIV

Switzerland
Gilead Sciences

Completed

Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)

HIV-1 Infection

United States, Spain, United Kingdom, Netherlands, Germany, Canada, Sweden, Switzerland, Italy, Belgium, Puerto Rico, France
Insel Gruppe AG, University Hospital Bern

Withdrawn

Micro Glucagon During Exercise in Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

Switzerland
University Hospital Inselspital, Berne

Terminated

The OpenAPS_ShadowMode Study

Type1diabetes

Switzerland
University Children's Hospital, Zurich

Completed

Evaluation of an Early Screener to Identify Long-term Problems With Regard to Metabolic Control and Treatment Adherence Among Children and Adolescents With Type 1 Diabetes

Type 1 Diabetes

Switzerland
University Hospital Inselspital, Berne

Completed

Role of the Liver in Glucose Homeostasis Using Metabolic Imaging (LEMON)

Type 1 Diabetes | Bariatric Surgery Candidate

Switzerland
University Hospital, Basel, Switzerland

Completed

Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes (EXTYPE-1)

Diabetes Mellitus Type 1

Switzerland
Gilead Sciences

Completed

Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults

HIV-1 Infection

Spain, United States, United Kingdom, Switzerland, Germany, Canada, France, Belgium, Puerto Rico
Gilead Sciences

Completed

Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

HIV-1 Infection

Canada, United States, Puerto Rico, Spain, United Kingdom, France, Portugal, Netherlands, Belgium, Italy, Australia, Austria, Germany, Switzerland
University of Zurich
XOMA (US) LLC

Completed

Effects of XOMA 052 on Insulin Production in Type 1 Diabetes (LATE STAGE)

Diabetes Mellitus Type 1

Switzerland
Lia Bally
University of Zurich

Completed

Simplified Meal Approach Using Hybrid Closed-loop Insulin Delivery in Youth and Young Adults With Type 1 Diabetes (SMASH)

Type 1 Diabetes

Switzerland
XOMA (US) LLC
Juvenile Diabetes Research Foundation

Completed

Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes

Type 1 Diabetes

Switzerland
Merck Sharp & Dohme LLC

Active, not recruiting

Dose Ranging, Switch Study of Islatravir (ISL) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]

HIV-1 Infection

United States, France, Switzerland
University Hospital Inselspital, Berne

Completed

Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes (DE-CAF)

Placebo | Caffeine and Carbohydrate | Carbohydrate Only

Switzerland
Lia Bally

Active, not recruiting

Supporting Meal Management in Type 1 Diabetes (SUMMIT1)

Type 1 Diabetes

Switzerland
Sintetica SA
Cross S.A.

Completed

Dose-finding Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia

Phase 1: Pain Management | Phase 2: Pain Management

Switzerland
Ospedale San Raffaele
Juvenile Diabetes Research Foundation

Completed

Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet Transplantation (ECIT-1)

Type 1 Diabetes

Italy, Switzerland
University of Zurich

Completed

Overnight Feeding Study in Glycogen Storage Disease Type 1

Glycogen Storage Disease Type 1 (GSD 1)

Switzerland
Philippe Klee

Completed

Randomized Crossover Study to Test the Impact of Using a Software for Smartphones and Tablets in Treating Type 1 Diabetes

Quality of Life | Type 1 Diabetes | Hypoglycaemia

Switzerland
Institute of Molecular and Clinical Ophthalmology...

Recruiting

Function and Imaging Assessments for G1961E-associated Stargardt Disease (FIRSTORBIT)

Stargardt Disease | Stargardt Disease 1 | Fundus Flavimaculatus | Macular Degeneration, Stargardt | Macular Dystrophy With Flecks, Type 1

Switzerland
ANRS, Emerging Infectious Diseases

Terminated

Expectation, Motivation and Experience of HIV-patients Regarding Participation to an HIV Cure-related Clinical Trial (AMEP-EHVA T02)

HIV Seropositivity

Switzerland
University Hospital, Basel, Switzerland

Completed

Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues (SKIP)

Smoking Cessation | Craving | Weight Change, Body | Glucagon-like Peptide-1

Switzerland
Vista Klinik
University Hospital, Basel, Switzerland

Completed

Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy

Insulin-Dependent Diabetes Mellitus 1

Switzerland
Merck Sharp & Dohme LLC

Active, not recruiting

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)

HIV-1 Infection

United States, Australia, Canada, Colombia, Japan, South Africa, Switzerland, United Kingdom
GlaxoSmithKline

Completed

Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients

HIV Infection | HIV-1 Infection | Infection, Human Immunodeficiency Virus I

Netherlands, Finland, Ireland, Portugal, Switzerland
University of Zurich
Merck Sharp & Dohme LLC; Swiss HIV Cohort Study

Completed

Raltegravir in the Swiss HIV Cohort Study

HIV Infection

Switzerland
Vista Klinik
University Hospital, Zürich

Completed

Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy

Insulin-Dependent Diabetes Mellitus 1

Switzerland
Centre Hospitalier Universitaire Vaudois

Completed

Drug-drug Interactions Between Antiretroviral Drugs and Cardiovascular Drugs in Elderly Patients

Cardiovascular Diseases | HIV Infections | Drug Interactions

Switzerland

Clinical Trials on HIV-1 in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations